The Scientist

» cancer

Most Recent

Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.

0 Comments

image: Could Rapamycin Help Humans Live Longer?

Could Rapamycin Help Humans Live Longer?

By Anne N. Connor | March 1, 2018

From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.

3 Comments

Testing treatments on mini tumors may save time in identifying which therapies work best, a new study shows.   

4 Comments

image: Stem Cell Vaccine Protects Mice From Cancer

Stem Cell Vaccine Protects Mice From Cancer

By Ruth Williams | February 15, 2018

Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter.

1 Comment

Researchers were able to slow tumor growth in a mouse model of human ovarian cancer. 

0 Comments

image: DNA Robots Target Cancer

DNA Robots Target Cancer

By Abby Olena | February 12, 2018

Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.

0 Comments

image: Primitive Human Eggs Grown to Full Maturity in the Lab

Primitive Human Eggs Grown to Full Maturity in the Lab

By Ashley Yeager | February 9, 2018

The technique could combat infertility, but it's still not clear whether these eggs are normal and functional.

0 Comments

image: How Toxic is the World’s Most Popular Herbicide Roundup?

How Toxic is the World’s Most Popular Herbicide Roundup?

By Katarina Zimmer | February 7, 2018

Glyphosate, the active ingredient in Roundup, is designed to be toxic to plants, but scientists observe some untoward effects on animals in the lab. 

10 Comments

image: Opinion: Do Not Believe the Hype

Opinion: Do Not Believe the Hype

By Aymen I. Idris | February 5, 2018

Marijuana ointments as cancer treatments remain a distant prospect. 

0 Comments

The treatment also curbed the growth of nearby metastases that did not receive the drug.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process